Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

American Academy of Neurology Annual Meeting
In Vivo Maintenance of Human Regulatory T Cells during CD25 Blockade.
Neurovascular and Immuno-Imaging Symposium
Rituximab for relapsing-remitting multiple sclerosis.
Interferon β-secreting mesenchymal stem cells combined with minocycline attenuate experimental autoimmune encephalomyelitis.
The Effects of IFN-β 1a on the Expression of Inflammasomes and Apoptosis-Associated Speck-Like Proteins in Multiple Sclerosis Patients.
Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS.
Factors in Patient Empowerment: A Survey of an Online Patient Research Network.
Mast cell inflammasome activity in the meninges regulates EAE disease severity.
Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention-An Update.
Novartis announces Russian regulatory approval for Gilenya®, a once-daily oral multiple sclerosis therapy and first in a new class
The "poison chair" treatment for multiple sclerosis.
Intrathecal interferon reduces exacerbations of multiple sclerosis.
Thrombotic microangiopathy due to acquired ADAMTS13 deficiency in a patient receiving interferon-beta treatment for multiple sclerosis.
National MS Society: Patient Management, Care and Rehabilitation Research Grants
Contribution of different relapse phenotypes to disability in multiple sclerosis.
A validated gene regulatory network and GWAS identifies early regulators of T cell-associated diseases.
Clarity Extension Study
The endocannabinoid system and multiple sclerosis.
Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US Patients.
Multiple Sclerosis: An Update.
Oral Dimethyl Fumarate in Children With Multiple Sclerosis: A Dual-Center Study.
Annual incidence, prevalence, and mortality of multiple sclerosis in white South-African-born and in white immigrants to South Africa.
Mitoxantrone induces natural killer cell maturation in patients with secondary progressive multiple sclerosis.
Qiagen Webinar: Molecular Mechanisms of Neurodegeneration

Pages